ALA seems to be helpful in improving glucose homeostasis (decreased FBG, insulin, HOMA-IR and HbA1c) and lipid profile (decreased triglycerides, total cholesterol and LDL-cholesterol), and its effect on DPN is considered to be greater when used with conventional treatment in T2D patients experiencing neuropathic pain. This evidence concerns the gene INS and type 2 diabetes mellitus.